U.S. Department of Health & Human Services
Featured News
Image
Featured News
Offering buprenorphine medication to people with opioid use disorder in jail may reduce rearrest and reconviction
January 18, 2022
Offering medication therapy to people with opioid use disorder while they are in jail can significantly lower their risk of subsequent justice involvement, a study funded by the NIH HEAL Initiative® found. The study, which is part of the Justice Community Opioid Innovation Network (JCOIN) program, found buprenorphine treatment reduced risk of probation violation, reincarceration, and other court charges by one-third.
Read the News ReleaseLatest Research Spotlight
Image
Latest Research Spotlight
A Living Pain Circuit
Tissue chip-based model screens potential pain medications faster
Read the SpotlightFeatured Video
Emotional Well-Being and the Power of Connections to Fight the Opioid Epidemic
NIH Director Dr. Francis Collins and U.S. Surgeon General Dr. Vivek Murthy discuss how chronic stress and isolation have profound implications for health, productivity and happiness, and how love, compassion, and kindness show us the way forward.Research Spotlights
Read in-depth stories about research projects supported by the initiative.